IGF2BP2 and colorectal carcinoma: METTL3 can also enhance the expression of IFIT1 in a way dependent m6A-IGF2BP2/3, resulting in fusobacterium nucleatum-induced PD-L1 upregulation and cell proliferation in CRC (36).